Med Life (BSE:M) Enterprise Value: lei7,976 Mil (As of Jun. 30, 2026) ***


BSE:M Med Life SA BSE:M
91 GF Score
Price lei11.40
GF Value lei7.82
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Med Life Enterprise Value?

Med Life BSE:M 91 Enterprise Value is lei7,976 Mil as of Jun. 30, 2026. GuruFocus rates BSE:M with a GF Score™ of 91/100 and a GF Value™ of lei7.82 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Med Life's Enterprise Value is lei7,976 Mil. Med Life's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was lei83 Mil. Therefore, Med Life's EV-to-EBIT ratio for today is 96.25.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Med Life's Enterprise Value is lei7,976 Mil. Med Life's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was lei307 Mil. Therefore, Med Life's EV-to-EBITDA ratio for today is 26.00.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Med Life's Enterprise Value is lei7,976 Mil. Med Life's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was lei2,437 Mil. Therefore, Med Life's EV-to-Revenue ratio for today is 3.27.

EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations. As of today, Med Life's Enterprise Value is lei7,976 Mil. Med Life's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was lei154 Mil. Therefore, Med Life's EV-to-OCF ratio for today is 51.83.

EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Med Life's Enterprise Value is lei7,976 Mil. Med Life's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was lei9 Mil. Therefore, Med Life's EV-to-FCF ratio for today is 906.24.

*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.


Med Life  (BSE:M) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Med Life's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=7975.820/82.866
=96.25

Med Life's current Enterprise Value is lei7,976 Mil.
Med Life's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was lei83 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Med Life's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=7975.820/306.733
=26.00

Med Life's current Enterprise Value is lei7,976 Mil.
Med Life's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was lei307 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Med Life's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=7975.820/2437.423
=3.27

Med Life's current Enterprise Value is lei7,976 Mil.
Med Life's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was lei2,437 Mil.

4. EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations.

Med Life's EV-to-OCF for today is:

EV-to-OCF=Enterprise Value (Today)/Cash Flow from Operations (TTM)
=7975.820/153.871
=51.83

Med Life's current Enterprise Value is lei7,976 Mil.
Med Life's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was lei154 Mil.

5. EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow.

Med Life's EV-to-FCF for today is:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=7975.820/8.801
=906.24

Med Life's current Enterprise Value is lei7,976 Mil.
Med Life's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was lei9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Med Life Enterprise Value Related Terms


Med Life Enterprise Value Historical Data

* Premium members only.

The historical data trend for Med Life's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Med Life Enterprise Value Chart

Med Life Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,052.01 3,685.63 3,322.77 3,634.72 4,793.23

Med Life Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Mar26
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,793.23 5,141.04 5,362.90 5,985.49 8,156.30

BSE:M vs HCA, THC, DVA: Enterprise Value Comparison

For the Medical Care Facilities subindustry, Med Life's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Med Life Enterprise Value vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Med Life's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Med Life's Enterprise Value falls into.


BSE:M
91GF Score
Med Life SA BSE:M
Enterprise Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Med Life Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Med Life's Enterprise Value for the fiscal year that ended in Dec. 2024 is calculated as

Med Life's Enterprise Value for the quarter that ended in Mar. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Enterprise Value →
What does a Enterprise Value of lei7,976 Mil mean?
Med Life (BSE:M) has a Enterprise Value of lei7,976 Mil as of Jun. 30, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Med Life and its competitors.
Is Med Life's Enterprise Value too high?
Med Life's current Enterprise Value is lei7,976 Mil. Overall, Med Life has a GF Score™ of 91/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Med Life's Enterprise Value compare to HCA and THC?
Med Life's Enterprise Value of lei7,976 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Healthcare Providers & Services company?
A good Enterprise Value depends on the Healthcare Providers & Services industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Med Life and its competitors. Med Life's current Enterprise Value is lei7,976 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Med Life stock overvalued right now?
Based on GuruFocus' analysis, Med Life (BSE:M) is currently considered Significantly Overvalued. The stock's GF Value™ is lei7.82, compared to a current price of lei11.40 — trading 45.8% above its estimated fair value. The current Enterprise Value is lei7,976 Mil. Med Life's overall GF Score™ is 91/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Med Life (BSE:M), the current Enterprise Value is lei7,976 Mil as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Med Life (BSE:M) Overvalued in 2026?

Based on GuruFocus' analysis, Med Life stock appears to be overvalued. The current stock price of lei11.40 is trading 45.8% above its estimated GF Value™ of lei7.82. GuruFocus considers Med Life to be Significantly Overvalued.

Key valuation signals for BSE:M:

  • Enterprise Value: lei7,976 Mil
  • GF Value™: lei7.82 vs. price of lei11.40 (45.8% above fair value)
  • GF Score™: 91/100 with 4 warning signs

No single metric tells the full story. See the BSE:M stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Med Life Business Description

Other Exchanges 0RO5:UKO0C:Germany
Address Calea Grivitei, No. 365, District 1, Bucharest, ROU
Med Life SA is a healthcare provider in Romania. The Company's activity resides in the performance of healthcare services activities through medical centres with national coverage. It is engaged in the provision of rendering of medical services, rental of medical facilities and acquisition of materials and commodities. The company provides medical service through Hyper clinics in Arad, Bucharest, Braila, Brasov, Cluj, Constanta, Craiova, Galati, Iasi, Oradea, Ploiesti, Sibiu and Timisoara; Clinics, hospitals located in Bucharest, Arad, Sibiu, Brasov, Cluj and Ploiesti, Laboratories, Pharmacies and Dental Clinics.
91GF Score

Get the complete analysis for BSE:M

Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

lei11.40
Price
lei7.82
GF Value